Get the Weekly Intelligence Brief — top committee picks every Sunday.

ADPT vs EXEL

Adaptive Biotechnologies Corporation vs Exelixis — AI-powered side-by-side comparison
ADPT
Adaptive Biotechnologies Corporation
59
Watch
VS
EXEL
Exelixis
67
Buy
MetricADPTEXEL
AI Score 59 67
Price $25.39 $51.30
P/E Ratio -62.32× 15.60×
ROE -27.2% 36.2%
Revenue Growth YoY
Gross Margin 75.4% 96.5%
Debt / Equity 2.87× 0.09×
Dividend Yield 0.0% 0.0%
RSI (14) 67.3 41.0
Beta 2.088 0.422
Expected Upside +8.7%

AI Committee View

Current Innellis committee reasoning for ADPT versus EXEL.
EXEL leads by 8 points.

EXEL scores 67/100 (Buy) versus ADPT at 59/100 (Watch).

ADPT Committee View
50% agreement
6 analysts

The committee is genuinely divided. Growth Analyst sees a compelling case — revenue growing 50.1% yoy -- genuine top-line momentum. Value Analyst remains cautious — price-to-book of 11.3x prices in significant intangible value. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Revenue growing 50.1% YoY -- genuine top-line momentum — Growth
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • Price-to-book of 11.3x prices in significant intangible value — Value
  • ROE of only -32.6% -- cheap may mean cheap for a reason — Value
  • Weekly RSI at 85 -- overbought on the larger timeframe too — Technical
EXEL Committee View
67% agreement
6 analysts

The primary driver is low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock. The main limiting factor is price-to-book of 5.4x prices in significant intangible value. The committee is constructive but not yet at full conviction.

Bull Case
  • ROE of 42.5% shows genuine earnings power backing the valuation — Value
  • EPS growing 52.7% YoY — Growth
  • 5 consecutive earnings beats -- consistent execution — Growth
Bear Case
  • Price-to-book of 5.4x prices in significant intangible value — Value
  • MACD histogram negative -- bearish momentum — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ADPT Full Analysis EXEL Full Analysis